The use of organoids for disease modelling, drug discovery and personalised medicine has become increasingly popular. Processes for the generation and maintenance of organoids can be complex, requiring high technical awareness.
Additionally, some organoid models are unsuitable for storage and shipment by freeze/thaw. WellReady™ offers a simple solution to these challenges, allowing for the shipment of developed organoid models at ambient temperatures, supplying the end-user with a ready to use model.
You can access the full paper using the link below: